Real Labs, Actual Decisions With Actionable Six Sigma Metrics

17.07.25 13:00 Uhr

QuidelOrtho Announces Featured ADLM Session

SAN DIEGO, July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

Angela Armato, Core Lab Manager, United Health Services and UHS Hospitals

ADLM Session Details:

Session Title:

Real Labs, Real Decisions with Actionable Six Sigma Metrics

When:

Tuesday, July 29, 2025

Where:

McCormick Convention Center

Chicago, IL

Exhibit Hall, Theater 1

Time:

2:45 p.m. – 3:45 p.m. CT

Registration:

Space is limited. ADLM attendees can register for the session using
this link: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe
Media registered for ADLM – please reach out to Nikki Wheeler to
access the session at Nikki.Wheeler@QuidelOrtho.com


Real Labs, Real Decisions With Actionable Six Sigma Metrics Panelists:

Dr. Jared Jaeger
Clinical Science Liaison
QuidelOrtho
Moderator

Dr. Bremansu Osa-Andrews
Medical Director of Clinical
Chemistry and Clinical Assistant Professor
University of Florida PathLab

Gilles Attipoe
Director of Laboratory Services
St. Peter's University Hospital

Angela Armato
Core Lab Manager
United Health Services and UHS Hospitals

To learn more about Six Sigma and the value of using real-world data listen to "Sigma Metrics and the Value of Real World Evidence." In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.

Unable to attend ADLM? Register to watch a recording of the session: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.

About QuidelOrtho
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@QuidelOrtho.com

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

Media@QuidelOrtho.com

Gilles Attipoe, Director of Laboratory Services, St. Peter's University Hospital

Dr. Bremansu Osa-Andrews, Medical Director of Clinical Chemistry and Clinical Assistant Professor, University of Florida PathLab

Dr. Jared Jaeger, Clinical Science Liaison, QuidelOrtho, Moderator

QuidelOrtho Corporation (PRNewsfoto/QuidelOrtho Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/real-labs-actual-decisions-with-actionable-six-sigma-metrics-302507241.html

SOURCE QuidelOrtho Corporation

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Nachrichten zu Quidel Corp.

Wer­bung

Analysen zu Quidel Corp.

DatumRatingAnalyst
22.01.2018Quidel OverweightBarclays Capital
18.07.2017Quidel BuyCanaccord Adams
25.04.2017Quidel HoldCanaccord Adams
08.01.2016Quidel BuyCanaccord Adams
02.09.2015Quidel OverweightBarclays Capital
DatumRatingAnalyst
22.01.2018Quidel OverweightBarclays Capital
18.07.2017Quidel BuyCanaccord Adams
08.01.2016Quidel BuyCanaccord Adams
02.09.2015Quidel OverweightBarclays Capital
04.01.2011Quidel outperformWedbush Morgan Securities Inc.
DatumRatingAnalyst
25.04.2017Quidel HoldCanaccord Adams
03.03.2011Quidel neutralWedbush Morgan Securities Inc.
30.09.2009Quidel market performWilliam Blair
DatumRatingAnalyst
29.08.2006Update Quidel Corp.: Strong SellMatrix Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quidel Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen